CN202113444U - Special insulin syringe - Google Patents
Special insulin syringe Download PDFInfo
- Publication number
- CN202113444U CN202113444U CN2011202188182U CN201120218818U CN202113444U CN 202113444 U CN202113444 U CN 202113444U CN 2011202188182 U CN2011202188182 U CN 2011202188182U CN 201120218818 U CN201120218818 U CN 201120218818U CN 202113444 U CN202113444 U CN 202113444U
- Authority
- CN
- China
- Prior art keywords
- core bar
- crimping
- banking stop
- insulin
- syringe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
The utility model discloses a special insulin syringe, which comprises a core rod, a piston and an outer barrel. The core rod is inserted into the outer barrel, the piston is arranged in the outer barrel and disposed at the front end of the core rod, the outer barrel comprises a barrel body, a conical head and a handheld turned edge, the conical head is arranged at the front end of the barrel body, the handheld turned edge is disposed at the rear end of the barrel body, the front end of the conical head is connected with a syringe needle seat, a plurality of grooves are arranged on the core rod at intervals, limiting sheets embedded into the grooves are arranged on the turned edge and movably connected with the turned edge, and annular sheets locked by the limiting sheets are disposed at the rear of the core rod. The special insulin syringe has the advantages of simple structure, convenience in manufacture, simplicity in use, reliable injection, safety in carrying, low cost and easiness in popularization.
Description
Technical field
This utility model relates to a kind of syringe; Be specifically related to a kind of insulin special syringe; Have self-locking behind the injection predetermined close, can be repeatedly, the injection of multiple predetermined close, the injection termination back function of automatically syringe being ruined type, belong to technical field of medical.
Background technology
Since insulin comes out, treatment of diabetes is got into basic replacement therapy, thoroughly improved the passive and difficult situation that diabetic relies on other to earn a bare living and continue with glucose level control with the blood sugar lowering method.Because the method for any blood sugar control beyond the insulin all makes patient live in very in life, always and everywhere all still is a patient; And the application of insulin then can make diabetic live among the environment that is close to the normal person.
At present, the onset diabetes rate rises year by year, and according to statistics, world's sickness rate is on average 3～5%; China child sickness rate is 3%, and young above crowd's sickness rate surpasses 7%.The above morbidity about 10% of crowd in 50 years old.The treatment aspect, wherein about 2,000 ten thousand people of II type (non-insulin-dependent) morbidity adopt diet control and Drug therapy more, near normal value, can slow down the generation of complication with glucose level control; I type (insulin-dependent) diabetic then must use the method for injection of insulin, blood sugar control.
Injection (psychological need amount) insulin be considered to diabetes patient blood sugar control the most effectively, science, near the alternative medicine of human pancreas's excreting insulin.Insulin is a kind of protein, needs injection or take in human body through the method for venoclysis to play a role.(absorption process is just in experimentation under the mucosa); The loaded down with trivial details inconvenience of venoclysis, at present methods that adopt the disposable sterilized syringe injection more.China is still developing country; Because economics dictate, what generally adopt is prevailing 1.0ml disposable syringe, and its deficiency is: residual quantity is big; Can not repeatedly use; Carry inconvenience, the diabetes patient need inject the insulin of 2～3 fixed dosages every day, causes medical expense to increase so on the contrary; Developed countries patient (domestic also have import) but then novolin syringe that adopts multiple injection more, its core bar is the container (needing to change) of insulin-containing, and is reusable after changing special-purpose injection of insulin pin (7 in a box), is easy to carry; Deficiency is that cost is too high, (nearly hundred yuan one can be used about 7 times), and inconvenience is popularized.At present, along with the application of microelectric technique, have insulin infusion pump to occur, one in tens thousand of units do not popularize in developed country yet.
By on can know, need on the market a kind of inexpensive, easy to manufacture, use simple, safe and reliable insulin syringe.At present, also not seeing the technical scheme that can solve above-mentioned insufficient a kind of insulin syringe fully both at home and abroad is disclosed.
The utility model content
This utility model technical problem to be solved is to provide a kind of insulin syringe, to solve existing existing many weak points.This utility model has adopted different configurations on the basis of common disposable syringe (three-piece) structure, make it to have: little residual, multiple injection; Automatic blocking behind the per injection predetermined close; After all injecting liquid drug finished, syringe locking self-destruction can not be repeated to use.Have easy to manufacturely, simple in structure, easy to use, be easy to carry, with low cost, be beneficial to universal.This utility model is applicable to behind the replacing injection needle of insulin can be repeatedly, the injection of repetition, fixed dosage is used.
The technical problem of the required solution of this utility model, can realize through following technical scheme:
A kind of insulin special syringe comprises core bar, piston and urceolus, and said core bar inserts in the said urceolus, and said piston is arranged in the urceolus, and said piston is arranged at the front end of core bar; Said urceolus comprises that a stack shell is used for the crimping that handgrip is held with being arranged on the conehead of stack shell front end and being arranged on said stack shell rear end, and the front end of said conehead is connected with injecting needle base, it is characterized in that: be arranged at intervals with some grooves on the said core bar; The banking stop that embeds said groove is set on the said crimping, and said banking stop and crimping flexibly connect; Said core bar rear portion is provided with the ring segment of limited locking.
Said banking stop is hinged on the said crimping, and the crimping aperture is set on said crimping, and said banking stop is provided with convexity, and said banking stop is fixed on the said crimping through the convexity that embeds in the said crimping aperture.
One outstanding dead bolt is set on the said banking stop, and said dead bolt is embedded in the different recesses in said core bar propelling movement process.
Said core bar is the cross type core bar; On each support side arm of described cross type core bar, be arranged at intervals with some grooves; Groove on the said different support side arm is staggered arranges, and the spacing between the adjacent grooves on the different support side arm equates or do not wait.
The some scrollings that are acute angle with the arm face of said support side arm are set on each support side arm of described cross type core bar, and each scrolling is arranged between adjacent two grooves, and the coiling direction of adjacent two scrollings is opposite and symmetrical.
The front end of said piston is provided with the stem stem that is complementary with conehead.
The rear end of said core bar is provided with a pressure handle, and the convexity that increases friction is set on the said pressure handle.
The beneficial effect of this utility model:
This utility model is the same basically with common disposable syringe structure, and material is identical, and manufacturing process is identical, and cost does not increase; With the apparatus in comparison of existing insulin injection, have characteristics easy to manufacture, with low cost, economical and practical, especially be beneficial to basic unit and popularize use.
The core bar of this utility model adopts the cross type core bar; And on each support side arm of cross type core bar, be shaped on groove at interval; And be shaped on to roll over to turn at the crimping of said urceolus and fasten or rotating banking stop; One outstanding dead bolt is set on the banking stop, locks with the cooperation of different grooves, make syringe urceolus and core bar can form repeatedly the setting of (can be identical or different) fixed dosage through dead bolt; Make when this utility model is used for injection of insulin, be convenient to setting, control dosage.In addition core bar is provided with ring segment, and this ring segment can limited self-locking, and whole insulin syringe is locked in the self-destruction position, and all injection back syringe locking self-destructions that finishes of medicinal liquid are not used again.
This utility model has adopted outstanding stem stem type piston, and stem stem gets into urceolus conehead endoporus, can reduce drug residue, improves utilization ratio of drug, makes ID accurate, guarantees the enforcement of treatment Expected Results.
In sum, the utlity model has simple in structurely, easily manufactured, use simply, injection is reliable, and is safe to carry, with low cost, the advantage that is easy to promote.
Description of drawings
Further specify this utility model below in conjunction with the accompanying drawing and the specific embodiment.
Fig. 1 is the structural representation of this utility model.
Fig. 2 is the decomposing schematic representation of this utility model.
Fig. 3 is the structural representation of this utility model urceolus.
Fig. 4 is the structural representation of this utility model core bar.
Fig. 5 is this utility model structure of piston sketch map.
Label among the figure:
100 is core bar, and 110 is ring segment, and 120 are scrolling, and 130 is the support side arm, and 140 is groove, and 150 is pressure handle, and 200 is piston, and 210 is stem stem; 300 is urceolus, and 310 is conehead, and 320 is stack shell, and 330 is crimping, and 331 is banking stop, and 332 is dead bolt, and 333 is the crimping aperture, and 334 is protruding.
The specific embodiment
For the technological means, the creation characteristic that make this utility model, reach purpose and effect and be easy to understand and understand, below in conjunction with concrete diagram, further set forth this utility model.
A kind of insulin special syringe shown in Fig. 1-2 comprises core bar 100, piston 200 and urceolus 300, and core bar 100 inserts in the urceolus 300, and piston 200 is arranged at the front end of core bar 100.
As shown in Figure 3, urceolus 300 comprises a stack shell 320, and the front end of stack shell 320 is provided with conehead 310, and the rear end is provided with crimping 330.The front end of conehead 310 is connected with injecting needle base, and is porose at conehead 310 centers.The design of crimping 330 is conveniently to use held.Stack shell 320, conehead 310, crimping 330 can be arranged to integral structure.
Like Fig. 1,2, shown in 4, core bar 100 is the cross type core bar, and the some scrollings 120 that are 45 with the arm face of support side arm 160 are set on each support side arm 160 of cross type core bar at interval, and the coiling direction of adjacent two scrollings 120 is opposite and symmetrical.Be provided with groove 140 in adjacent two scrollings 120.Groove 140 staggered arranging on the different support side arm 160, the spacing between the adjacent grooves 140 on the different support side arm 160 equates or does not wait.
One outstanding dead bolt 332 is set on banking stop 331, and dead bolt 332 is complementary with the size of groove 140, makes dead bolt 332 can embed and pin groove 140.
Owing to the utlity model has the design of groove 140; Make syringe urceolus 300 and core bar 100 can form repeatedly the setting of fixed dosage, the spacing of groove 140 can equate or not wait, corresponding liquid dose just identical or different; When making injection of insulin, be convenient to setting and control to dosage.
As shown in Figure 4,110 limited 331 lockings of the ring segment at core bar 100 rear portions, syringe locking self-destruction is not used again, and plays the function of locking, self-destruction.In the rear end of core bar 100 pressure handle 150 is set, pressure handle 150 has strip projected parts, plays to increase friction, anti-skidding effect.
As shown in Figure 5, the front end of piston 200 is provided with the cylindrical stem stem 210 of a convexity, and cylindrical stem stem 210 is complementary with the interior hole dimension of conehead 310, and stem stem 210 can stretch in the conehead 210 of urceolus, and is residual to eliminate medicinal liquid.
The method for using of this utility model:
During use, as ordinary syringe, open fractional pack; Take out syringe, after the inspection utensil is no abnormal, extract medicinal liquid behind certain scale (capacity); Core bar 100 is reversed; Support side arm 160 on the cross type core bar is 45 ° with crimping 330 major axis of urceolus 300, and the banking stop 331 with crimping 330 1 sides inwardly turns to user mode or inwardly turn to user mode then, again core bar 100 is rotated 90 °; Dead bolt 332 on the banking stop 331 is inserted in any one support side arm 160 groove 140 bottom of core bar 210, forms locking core bar 210.
When needing injection; Push core bar 100 and inject, after accomplishing the predetermined close injection, in another groove 140 of the dead bolt 332 on the banking stop 331 top on the support side arm 160 of core bar 210; Dead bolt 332 on limited once more 331 of the core bar 100 pins; The core bar 100 of syringe is braked, and can not continue injection, can not be extracted to returning.
After changing entry needle, rotate 90 ° of core bars once more after, can carry out next time and inject.
Same quadrat method accomplishes the 3rd, 4 ... Inferior injection is finished by whole injections until medicinal liquid, 110 limited 331 lockings of the ring segment of core bar 100 rear ends, and syringe locking self-destruction is not used again.
This syringe also can be used as ordinary syringe and uses, and is exactly with 45 ° of core bar rotations, makes the restriction of the groove disengaging banking stop on the cross core bar sidewall.Can under artificial control, arbitrarily inject the medicinal liquid of predetermined close according to scale.
More than show and described the advantage of ultimate principle, principal character and this utility model of this utility model.The technical staff of the industry should understand; This utility model is not restricted to the described embodiments; The principle of describing in the foregoing description and the description that this utility model just is described; This utility model also has various changes and modifications under the prerequisite that does not break away from this utility model spirit and scope, and these variations and improvement all fall in this utility model scope that requires protection.This utility model requires protection domain to be defined by appending claims and equivalent thereof.
Claims (7)
1. an insulin special syringe comprises core bar, piston and urceolus, and said core bar inserts in the said urceolus, and said piston is arranged in the urceolus, and said piston is arranged at the front end of core bar; Said urceolus comprises that a stack shell is used for the crimping that handgrip is held with being arranged on the conehead of stack shell front end and being arranged on said stack shell rear end, and the front end of said conehead is connected with injecting needle base, it is characterized in that: be arranged at intervals with some grooves on the said core bar; The banking stop that embeds said groove is set on the said crimping, and said banking stop and crimping flexibly connect; Said core bar rear portion is provided with the ring segment of limited locking.
2. insulin special syringe as claimed in claim 1; It is characterized in that; Said banking stop is hinged on the said crimping; The crimping aperture is set on said crimping, and said banking stop is provided with convexity, and said banking stop is fixed on the said crimping through the convexity that embeds in the said crimping aperture.
3. according to claim 1 or claim 2 insulin special syringe is characterized in that, an outstanding dead bolt is set on the said banking stop, and said dead bolt is embedded in the different recesses in said core bar propelling movement process.
4. insulin syringe as claimed in claim 1; It is characterized in that; Said core bar is the cross type core bar; On each support side arm of described cross type core bar, be arranged at intervals with some grooves, the groove on the said different support side arm is staggered arranges, and the spacing between the adjacent grooves on the different support side arm equates or do not wait.
5. insulin special syringe as claimed in claim 4; It is characterized in that; The some scrollings that are acute angle with the arm face of said support side arm are set on each support side arm of described cross type core bar; Each scrolling is arranged between adjacent two grooves, and the coiling direction of adjacent two scrollings is opposite and symmetrical.
6. insulin special syringe as claimed in claim 1 is characterized in that, the front end of said piston is provided with the stem stem that is complementary with conehead.
7. insulin special syringe as claimed in claim 1 is characterized in that the rear end of said core bar is provided with a pressure handle, and the convexity that increases friction is set on the said pressure handle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011202188182U CN202113444U (en) | 2011-06-24 | 2011-06-24 | Special insulin syringe |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011202188182U CN202113444U (en) | 2011-06-24 | 2011-06-24 | Special insulin syringe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202113444U true CN202113444U (en) | 2012-01-18 |
Family
ID=45454543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011202188182U Expired - Fee Related CN202113444U (en) | 2011-06-24 | 2011-06-24 | Special insulin syringe |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202113444U (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105561432A (en) * | 2015-12-19 | 2016-05-11 | 安徽宏宇五洲医用器材有限公司 | Non-gravity type suspension-avoiding transfusion device |
| CN106964027A (en) * | 2017-05-16 | 2017-07-21 | 上海博洽医疗器械有限公司 | The interface of the instrument used for injection of injector for medical purpose |
| CN107050576A (en) * | 2017-05-16 | 2017-08-18 | 上海博洽医疗器械有限公司 | Safety injector |
| CN107569745A (en) * | 2017-10-18 | 2018-01-12 | 上海博洽医疗器械有限公司 | The overcoat of safety injector |
| CN108686728A (en) * | 2018-05-18 | 2018-10-23 | 中国石油化工股份有限公司 | Multrirange liquid automatic quantitation pipette device |
| CN110913926A (en) * | 2017-06-08 | 2020-03-24 | 诺瓦提斯公司 | Injection device and injection liquid conveying system |
| CN111207959A (en) * | 2020-03-04 | 2020-05-29 | 常州进出口工业及消费品安全检测中心 | Oxidizing liquid sample injector |
| CN111450355A (en) * | 2020-03-23 | 2020-07-28 | 中国人民解放军海军军医大学 | Needle-prick-proof syringe capable of being preloaded with medicine |
-
2011
- 2011-06-24 CN CN2011202188182U patent/CN202113444U/en not_active Expired - Fee Related
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105561432A (en) * | 2015-12-19 | 2016-05-11 | 安徽宏宇五洲医用器材有限公司 | Non-gravity type suspension-avoiding transfusion device |
| CN106964027A (en) * | 2017-05-16 | 2017-07-21 | 上海博洽医疗器械有限公司 | The interface of the instrument used for injection of injector for medical purpose |
| CN107050576A (en) * | 2017-05-16 | 2017-08-18 | 上海博洽医疗器械有限公司 | Safety injector |
| WO2018209792A1 (en) * | 2017-05-16 | 2018-11-22 | 上海博洽医疗器械有限公司 | Safe syringe |
| CN107050576B (en) * | 2017-05-16 | 2020-01-14 | 上海博洽医疗器械有限公司 | Safety syringe |
| CN106964027B (en) * | 2017-05-16 | 2020-05-26 | 上海博洽医疗器械有限公司 | Interface of injection device of medical injector |
| CN115054777A (en) * | 2017-06-08 | 2022-09-16 | 诺瓦提斯公司 | Injection device and injection liquid conveying system |
| CN110913926A (en) * | 2017-06-08 | 2020-03-24 | 诺瓦提斯公司 | Injection device and injection liquid conveying system |
| JP7244442B2 (en) | 2017-06-08 | 2023-03-22 | ノバルティス アーゲー | Injection device and injection solution transfer system |
| US11554215B2 (en) | 2017-06-08 | 2023-01-17 | Novartis Ag | Injection device and injection solution transferring system |
| JP2020522351A (en) * | 2017-06-08 | 2020-07-30 | ノバルティス アーゲー | Injection device and injection solution transfer system |
| CN107569745A (en) * | 2017-10-18 | 2018-01-12 | 上海博洽医疗器械有限公司 | The overcoat of safety injector |
| CN108686728A (en) * | 2018-05-18 | 2018-10-23 | 中国石油化工股份有限公司 | Multrirange liquid automatic quantitation pipette device |
| CN111207959A (en) * | 2020-03-04 | 2020-05-29 | 常州进出口工业及消费品安全检测中心 | Oxidizing liquid sample injector |
| CN111450355B (en) * | 2020-03-23 | 2022-05-10 | 中国人民解放军海军军医大学 | Needle-prick-proof injector capable of pre-loading medicine |
| CN111450355A (en) * | 2020-03-23 | 2020-07-28 | 中国人民解放军海军军医大学 | Needle-prick-proof syringe capable of being preloaded with medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN202113444U (en) | Special insulin syringe | |
| CN101979108B (en) | Insulin syringe | |
| CN101862490B (en) | Self-destruction insulin syringe capable of replacing needle | |
| CN103550848B (en) | Needle-free syringe | |
| CN107405460A (en) | It is provided with a pin for safety system | |
| CN109200396B (en) | Needleless injection connection device | |
| CN105764551B (en) | Shell for medication injections device | |
| CN202699778U (en) | Clamp type full-automatic injection pen | |
| CN205460227U (en) | Needleless spring syringe | |
| CN208958995U (en) | Insulin pen injectors syringe needle wins surge drum | |
| CN2882645Y (en) | Medical semi-automatic syringe | |
| CN202822342U (en) | Safe injector | |
| CN102205155A (en) | Doser for transfusion | |
| CN205460225U (en) | Disposable needleless spring syringe | |
| CN207575512U (en) | A kind of plant medicine needle with drug storage | |
| CN202409548U (en) | Subcutaneous implantable antipsychotics slow-release bar device | |
| CN208756699U (en) | A kind of syringe | |
| CN201135667Y (en) | Filtration type safety type syringe | |
| CN216725424U (en) | Insulin syringe | |
| CN201076655Y (en) | Disposable self-destroying syringe | |
| CN106999679A (en) | Drive mechanism for injection device | |
| CN202446596U (en) | Automatic retraction type safe self-destruction disposable injector | |
| CN108245744A (en) | Insulin pen injectors syringe needle wins surge drum and its wins collection method | |
| CN202437870U (en) | Disposable syringe | |
| CN204745216U (en) | Safe type insulin pen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANGHAI JUMIN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHANGHAI SHUANGGE INDUSTRIAL CO., LTD. Effective date: 20141014 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20141014 Address after: 201400 Shanghai City, Fengxian District Hangzhou Highway No. 1888 building Sixth Patentee after: SHANGHAI JUMIN BIOLOGICAL TECHNOLOGY CO., LTD. Address before: 201400, Shanghai, Fengxian District Jianghai Jianghai Economic Zone, Shanghai Hangzhou Highway No. 1888 Patentee before: Double-Dove Industrial Co., Ltd. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 201400 Shanghai City, Fengxian District Hangzhou Highway No. 1888 building Sixth Patentee after: Poly Biological Technology Co Ltd Address before: 201400 Shanghai City, Fengxian District Hangzhou Highway No. 1888 building Sixth Patentee before: SHANGHAI JUMIN BIOLOGICAL TECHNOLOGY CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120118 Termination date: 20180624 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |